STAT6 and lymphoma: One such recurrent mutation was in signal transducer and activator of transcription 6 (STAT6) at residue D419, found in 36% of relapsed/refractory GCB-DLBCL (rrDLBCL) and transformed lymphoma (rrTLy) samples [9].